Beijing Pharscin

Pharscin Pharma is a prominent Chinese pharmaceutical company that integrates research, development, manufacturing, and sales of chemical drugs and modern Traditional Chinese Medicine (TCM). The company is a market leader in the digestive system therapeutic area, particularly with its proprietary TCM products like Banzhalan for gastritis and chemical drugs like Gantone. Pharscin also maintains a significant presence in the cardiovascular, respiratory, and psychiatric fields, with a growing pipeline of innovative small molecules targeting oncology and metabolic diseases. Its R&D operations are centered in Beijing under the name Beijing Pharscin Pharmaceutical Technology, while its large-scale GMP manufacturing facilities are located in Chongqing. The company is publicly listed on the Shenzhen Stock Exchange.